Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025–34: a mathematical modelling study
Nicolas A Menzies PhD , Tyler S Brown MD , Jeffrey W Imai-Eaton PhD , Prof Peter J Dodd PhD , Prof Ted Cohen MD DrPH , Leonardo Martinez PhD
{"title":"Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025–34: a mathematical modelling study","authors":"Nicolas A Menzies PhD , Tyler S Brown MD , Jeffrey W Imai-Eaton PhD , Prof Peter J Dodd PhD , Prof Ted Cohen MD DrPH , Leonardo Martinez PhD","doi":"10.1016/S2352-4642(25)00218-4","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Children are at increased risk of developing and dying from tuberculosis. We aimed to estimate the additional paediatric tuberculosis deaths that could occur over 2025–34 if programmes supported by US bilateral health aid and The Global Fund to Fight AIDS, Tuberculosis, and Malaria are discontinued.</div></div><div><h3>Methods</h3><div>For this modelling study we collated data on funding sources for tuberculosis and HIV programmes in low-income and middle-income countries and constructed scenarios representing reductions in health aid from 2025. Using calibrated transmission-dynamic models of tuberculosis and HIV for 130 countries, we projected the discontinuation of tuberculosis and HIV treatment services under several funding reduction scenarios, and how this would affect paediatric (ages 0–14 years) tuberculosis exposure and treatment access. We projected paediatric tuberculosis incidence and mortality over 2025–34 to calculate the impact of funding reductions.</div></div><div><h3>Findings</h3><div>Compared to maintenance of pre-2025 service levels, withdrawal of services currently supported by US bilateral health aid is projected to result in an additional 2·5 million (95% uncertainty interval [UI] 1·8–3·3) paediatric tuberculosis cases and 340 000 (240 000–460 000) tuberculosis deaths over 2025–34. Withdrawal of US support to The Global Fund and reductions in non-US contributions are projected to result in an additional 8·9 million (95% UI 6·9–11·5) paediatric tuberculosis cases and 1·5 million (1·1–2·0) tuberculosis deaths, more than double the number of paediatric tuberculosis deaths expected with continued service levels (1·10 million [0·89–1·38]). Impacts were greatest in the WHO African and South-East Asia regions. Restoration of services in 2026 was projected to lead to a substantially smaller number of additional deaths (39 000 [95% UI 29 000–51 000]).</div></div><div><h3>Interpretation</h3><div>Without actions to restore discontinued services, cuts to health aid for tuberculosis and HIV programmes could result in millions of additional childhood tuberculosis cases and deaths in low-income and middle-income countries over the next decade.</div></div><div><h3>Funding</h3><div>None.</div></div>","PeriodicalId":54238,"journal":{"name":"Lancet Child & Adolescent Health","volume":"9 11","pages":"Pages 787-795"},"PeriodicalIF":15.5000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Child & Adolescent Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352464225002184","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Children are at increased risk of developing and dying from tuberculosis. We aimed to estimate the additional paediatric tuberculosis deaths that could occur over 2025–34 if programmes supported by US bilateral health aid and The Global Fund to Fight AIDS, Tuberculosis, and Malaria are discontinued.
Methods
For this modelling study we collated data on funding sources for tuberculosis and HIV programmes in low-income and middle-income countries and constructed scenarios representing reductions in health aid from 2025. Using calibrated transmission-dynamic models of tuberculosis and HIV for 130 countries, we projected the discontinuation of tuberculosis and HIV treatment services under several funding reduction scenarios, and how this would affect paediatric (ages 0–14 years) tuberculosis exposure and treatment access. We projected paediatric tuberculosis incidence and mortality over 2025–34 to calculate the impact of funding reductions.
Findings
Compared to maintenance of pre-2025 service levels, withdrawal of services currently supported by US bilateral health aid is projected to result in an additional 2·5 million (95% uncertainty interval [UI] 1·8–3·3) paediatric tuberculosis cases and 340 000 (240 000–460 000) tuberculosis deaths over 2025–34. Withdrawal of US support to The Global Fund and reductions in non-US contributions are projected to result in an additional 8·9 million (95% UI 6·9–11·5) paediatric tuberculosis cases and 1·5 million (1·1–2·0) tuberculosis deaths, more than double the number of paediatric tuberculosis deaths expected with continued service levels (1·10 million [0·89–1·38]). Impacts were greatest in the WHO African and South-East Asia regions. Restoration of services in 2026 was projected to lead to a substantially smaller number of additional deaths (39 000 [95% UI 29 000–51 000]).
Interpretation
Without actions to restore discontinued services, cuts to health aid for tuberculosis and HIV programmes could result in millions of additional childhood tuberculosis cases and deaths in low-income and middle-income countries over the next decade.
期刊介绍:
The Lancet Child & Adolescent Health, an independent journal with a global perspective and strong clinical focus, presents influential original research, authoritative reviews, and insightful opinion pieces to promote the health of children from fetal development through young adulthood.
This journal invite submissions that will directly impact clinical practice or child health across the disciplines of general paediatrics, adolescent medicine, or child development, and across all paediatric subspecialties including (but not limited to) allergy and immunology, cardiology, critical care, endocrinology, fetal and neonatal medicine, gastroenterology, haematology, hepatology and nutrition, infectious diseases, neurology, oncology, psychiatry, respiratory medicine, and surgery.
Content includes articles, reviews, viewpoints, clinical pictures, comments, and correspondence, along with series and commissions aimed at driving positive change in clinical practice and health policy in child and adolescent health.